Bio-Path Holdings (BPTH)
:BPTH
US Market
Advertisement

Bio-Path Holdings (BPTH) Ownership - Who Owns Bio-Path Holdings?

Compare
482 Followers

Bio-Path Holdings (BPTH) Ownership Overview

3.04%96.96%
3.04% Other Institutional Investors
96.96% Public Companies and
Individual Investors
The ownership structure of Bio-Path Holdings (BPTH) stock is a mix of institutional, retail, and individual investors. , and 96.96% is owned by Public Companies and Individual Investors.
The ownership structure of Bio-Path Holdings (BPTH) stock is a mix of institutional, retail, and individual investors. , 3.04% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,164,434Insider62.16%800,487
1,633,911Insider19.67%253,256
13,502Institution0.16%2,498
13,502Institution0.16%2,228

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
13,502Institution0.16%2,498

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Bio-Path Holdings (BPTH)?
Currently, no data Available
What percentage of Bio-Path Holdings (BPTH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.04% of Bio-Path Holdings (BPTH) stock is held by institutional investors.
    What percentage of Bio-Path Holdings (BPTH) stock is held by retail investors?
    According to the latest TipRanks data, approximately 96.96% of Bio-Path Holdings (BPTH) stock is held by retail investors.
      Who owns the most shares of Bio-Path Holdings (BPTH)?
      Peter Henry Nielsen owns the most shares of Bio-Path Holdings (BPTH).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis